---
title: "Dual LNP‑mRNA delivery restores hepatic function in mouse model of trifunctional protein deficiency"
id: "biorxiv-4-dual-mrna-delivery-corrects-physical-and-biochemical-deficits-in-a-mouse-model"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-4-dual-mrna-delivery-corrects-physical-and-biochemical-deficits-in-a-mouse-model"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1?rss=1"
published_at: "2026-11-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Dual LNP‑mRNA delivery restores hepatic function in mouse model of trifunctional protein deficiency
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-4-dual-mrna-delivery-corrects-physical-and-biochemical-deficits-in-a-mouse-model
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1?rss=1)
- **Published At:** 2026-11-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study addressed **mitochondrial trifunctional protein deficiency (TFP-D)**, a long-chain fatty acid oxidation disorder caused by variants in HADHA or HADHB, using a dual mRNA replacement strategy delivered in lipid nanoparticles (LNPs). - Investigators delivered both Hadha and Hadhb mRNA to a moderate‑severity, hepatic‑onset TFP‑D mouse model; dual delivery restored biochemical pathways in cells and tissue where single‑subunit replacement did not. - In cultured TFP‑D mouse fibroblasts, dual mRNA—but not single‑subunit replacement—rescued long‑chain fatty acid oxidation, indicating a dominant negative effect from the endogenous M404K Hadhb variant. - Intravenous administration of dual **LNP‑mRNA** in vivo restored hepatic TFP expression, lowered circulating long‑chain acylcarnitines, and improved physical performance metrics in aged TFP‑D mice. - The study team observed up to a 71.6% improvement in cold tolerance test (CTT) performance versus untreated controls after dual mRNA LNP delivery. - The authors reported that dual subunit LNP‑mRNA delivery may be broadly applicable to other long‑chain fatty acid oxidation disorders; the preprint status indicates findings have not been peer reviewed. - The abstract did not report detailed dosing regimens, duration of effect, long‑term safety data, or full methodological parameters; those elements appear in the full text and supplementary material rather than the abstract alone.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=rnWKi9Mftfdl5btUYwdyghe4N5RmIiTNfN4D30mGCH4-1795334451.9275146-1.2.1.1-SqOTErzeNEzBsMAaVcOAUzNEDZGYWfY0frOgIxF2SGYdqNo.Q3VsV4XNjbsoGwUA) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Dual mRNA delivery corrects physical and biochemical deficits in a mouse model of hepatic onset trifunctional protein deficiency [ View ORCID Profile](http://orcid.org/0000-0002-9085-3650)Troy von Beck, Tatiana Terranova, Bahjat Fadi Marayati, Haoyue Zhang, Liyang Zhu, Songtao Li, Bruce R Donald, Sarah P Young, Myles Lindsay, Christopher A Todd, Dwight D Koeberl doi: https://doi.org/10.64898/2026.11.19.767734 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Troy von Beck Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Troy%2Bvon%2BBeck%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=von%20Beck%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ATroy%2Bvon%2BBeck%2B) * [ORCID record for Troy von Beck](http://orcid.org/0000-0002-9085-3650 "Open in new tab") * For correspondence: tav17@duke.edu Tatiana Terranova Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tatiana%2BTerranova%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Terranova%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ATatiana%2BTerranova%2B) Bahjat Fadi Marayati Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bahjat%2BFadi%2BMarayati%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Marayati%20BF&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ABahjat%2BFadi%2BMarayati%2B) Haoyue Zhang Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Haoyue%2BZhang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zhang%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AHaoyue%2BZhang%2B) Liyang Zhu Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Liyang%2BZhu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zhu%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALiyang%2BZhu%2B) Songtao Li Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Songtao%2BLi%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Li%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASongtao%2BLi%2B) Bruce R Donald Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bruce%2BR%2BDonald%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Donald%20BR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ABruce%2BR%2BDonald%2B) Sarah P Young Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sarah%2BP%2BYoung%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Young%20SP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASarah%2BP%2BYoung%2B) Myles Lindsay Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Myles%2BLindsay%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Lindsay%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMyles%2BLindsay%2B) Christopher A Todd Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christopher%2BA%2BTodd%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Todd%20CA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AChristopher%2BA%2BTodd%2B) Dwight D Koeberl Duke University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dwight%2BD%2BKoeberl%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Koeberl%20DD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADwight%2BD%2BKoeberl%2B) * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5986163/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5986163/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5986163/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5986163/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5986163/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Mitochondrial trifunctional protein deficiency (TFP-D) is a rare, life threatening long-chain fatty acid oxidation disorder caused by variants in either the HADHA or HADHB subunits, leading to toxic metabolite accumulation and systemic energy deficiency. Current dietary management strategies are only partially effective and fail to prevent long term morbidity and mortality. Here, we developed a lipid nanoparticle (LNP) mediated mRNA replacement strategy to restore TFP function in a moderate severity TFP-D mouse model by delivering both Hadha and Hadhb mRNA. In cultured TFP-D mouse fibroblasts, dual mRNA delivery, but not single subunit replacement, rescued long-chain fatty acid oxidation and revealed a dominant negative effect exerted by the endogenous M404K variant Hadhb. In vivo, intravenous administration of dual mRNA-LNPs restored hepatic TFP expression, reduced circulating long-chain acylcarnitines, and improved physiological performance in aged TFP‑D mice. Notably, intravenous delivery of dual mRNA LNPs significantly rescued cold tolerance test (CTT) performance by up to 71.6% compared to untreated and healthy controls. Together, these findings establish dual subunit LNP‑mRNA delivery as a promising therapeutic strategy for TFP‑D and support its potential applicability to other long-chain fatty acid oxidation disorders. ### Competing Interest Statement B.R.D. is a founder of Ten63 Therapeutics Inc. T.V.B, T.T., and D.D.K. have filed provisional patents related to this work. ## Funder Information Declared National Institute of General Medical Sciences, https://ror.org/04q48ey07, R35 GM-144042 Duke University, https://ror.org/00py81415 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.18.767671v1 "Interspecies differences in lamina cribrosa fiber composition and architecture might arise from differences in optic nerve head size and mechanical constraints")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.18.767574v1 "Nuclear quantum effects on ion permeation through the open transient receptor potential melastatin 7 pore: A continuum-electrostatics estimate") Posted November 21, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/21/2026.11.19.767734.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.19.767734v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Dual mRNA delivery corrects physical and biochemical deficits in a mouse model of hepatic onset trifunctional protein deficiency Troy von Beck, Tatiana Terranova, Bahjat Fadi Marayati, Haoyue Zhang, Liyang Zhu, Songtao Li, Bruce R Donald, Sarah P Young, Myles Lindsay, Christopher A Todd, Dwight D Koeberl bioRxiv 2026.11.19.767734; doi: https://doi.org/10.64898/2026.11.19.767734 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767734v1%26text%3DDual%2520mRNA%2520delivery%2520corrects%2520physical%2520and%2520biochemical%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520hepatic%2520onset%2520trifunctional%2520protein%2520deficiency "Share this on Twitter") [![Facebook logo](https://www.b
## Related Clinical Research

- [Training background shapes acute exercise-induced extracellular vesicle proteomes in humans](https://medichelpline.com/clinical-feed/biorxiv-5-training-background-shapes-the-exercise-induced-extracellular-vesicle-proteome.md)
- [MicroBioAgent: autonomous AI for end-to-end microbiome analysis](https://medichelpline.com/clinical-feed/biorxiv-3-microbioagent-an-ai-agent-for-automated-microbiome-analysis.md)
- [REMI: Free tool enabling truncated proximity searches in PubMed](https://medichelpline.com/clinical-feed/medrxiv-23-remi-a-free-tool-for-truncated-proximity-searching-in-pubmed.md)
- [Motherly Plus trial: Smartphone‑assisted single‑session psychotherapy for postpartum depression](https://medichelpline.com/clinical-feed/medrxiv-3-motherly-plus-study-protocol-of-a-randomized-controlled-trial-evaluating-a.md)
- [Creatine for Healthy Aging: Examining a Decade of Use](https://medichelpline.com/clinical-feed/medical-news-today-0-age-appropriate-i-ve-taken-creatine-for-10-years-does-it-help-healthy-aging.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.